Importance of early detection of colorectal cancer;Značaj ranog otkrivanja raka debelog crijeva

Medicina

Volumn 44, Issue 1, 2008, Pages 7-15

  Štimac, Davor ^a   Katičić, Miroslava ^b   Kujundžić, Milan ^c   Ljubičić, Neven ^d   Poropat, Goran ^a   Bokun, Tomislav ^c  

^a KBC RIJEKA   (Croatia)

^b University of Zagreb   (Croatia)

^c University of Zagreb   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Colorectal cancer; Early detection; Epidemiology; Screening

Indexed keywords

EID: 67650239174     PISSN: 00257729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. World Health Organization Press Release. National Cancer Control Programmes: Policies and Managerial Guidelines. 2nd ed. Geneva: WHO, 2002.
2. Hrvatski zavod za javno zdravstvo. Incidencija raka u Hrvatskoj. Bilten br. 30 (2005). Zagreb: Hrvatski zavod za javno zdravstvo, 2007.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
4. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ 2000;321:805-8.
5. th ed. Philadelphia: WB Saunders, 2006:2759-810.
6. Ballinger AB, Anggiansah C. Colorectal cancer. BMJ 2007;335:715-8.
7. Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, Church TR, et al. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomised trial. J Natl Cancer Inst 2007;99:129-36.
8. Wallace K, Baron JA, Cole BF, Sandler RS, Karagas MR, Beach MA, et al. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst 2004;96:921-5.
9. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999;340:101-7.
10. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
11. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-90.
12. Wauters H, Van Casteren V, Buntinx F. Rectal bleeding and colorectal cancer in general practice: diagnostic study. BMJ 2000;321:998-9.
13. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Socitey guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin 1997;47:154-60.
14. Carraro PG, Segala M, Cesana BM, Tiberio G. Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum 2001;44:243-50.
15. Hundt W, Braunschweig R, Reiser M. Evaluation of spiral CT in staging of colon and rectum carcinoma. Eur Radiol 1999;9:78-84.
16. Imam K, Bluemke DA. MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin N Am 2000;8:741-56.
17. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA.. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998;227:319-23.
18. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Stemberg SS, et al. Riski of CRC in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996;334:82-7.
19. Selby JV. Explaining recent decline in colorectal cancer incidence: was it the sigmoidoscope? Am J Med 2000;109:332-4.
20. Davila RE, Rajan E, Adler R, Egan J, Hirota WK, Leighton JA et al. ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointest Endosc 2005;61:1-7.
21. Simmons DT, Baron TH. Technology insight: Enteral stenting and new technology. Nat Clin Pract Gastroenterol Hepatol 2005;2:365-74.
22. Binkert CA, Ledermann H, Jost R, Saurenmann P, Decurtins M, Zollikofer CL. Acute colonic obstruction: clinical aspects and cost-effectiveness of preoparative and palliative treatment with self-expanding metallic stents: a preliminary report. Radiology 1998;206:199-204.
23. Lo SK. Metallic stenting for colorectal obstruction. Gastrointest Endosc Clin N Am 1999;9:459-77.
24. Gevers AM, Macken E, Hiele M, Rutgeerts P. Endoscopic laser therapy for palliation of patients with distal colorectal carcinoma: analysis of factors influencing longterm outcomes. Gastrointest Endosc 2000;51:580-5.
25. Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer 1996;78:918-26.
26. Beart RW, Steele GD Jr, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002;45:585-92.
27. th ed. Zuidema GD, Yeo CJ (eds). Philadelphia: WB Saunders Company, 2002.
28. nd ed. Philadelphia: Elsevier Mosby, 2005;379-88.
29. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 2005;97:219-25.
30. Cassidy J, Douillard YT, Twelves C, McKendrick JJ, Scheithauer W, Bustová I et al. Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. Br J Cancer 2006;94:1122-9.
31. Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005;353:2696-704.
32. Saltz LB, Niedzwicki D, Hoillis D, Goldberg RM, Hantel A, Thomas JP et al. Irinotecan plus fluorouracil/leucovorin versus fluorouracil/leucovorin alone in stage III colon cancer (abstract). Proc Am Soc Clin Oncol 2004; 23:246a.
33. Van Cutsem E, Labianca R, Hossfeld D, Niederle N, Possinger K, Labianca R et al. Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) versus 5-FU/FA in stage III colon cancer patients (abstract). J Clin Oncol 2005;23:1090s.
34. Anonymous. Expectancy of primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol 1992;10:904-11.
35. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306:752-5.
36. Giantonio BJ, Catalano PJ, Meropol NJ, Mitchell EP, Schwartz MA, Alberts SR et al. High-dose bevacizumab in combination with FOLFOX4 improves survival in patients with previously treated advanced colorectal cancer: results from the Eastern Cooperative Oncology Group (ECOG) study E 3200. Abstracts from 2005 Gastrointestinal Cancers Symposium, 2005;A169a.
37. Anonymous. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International multicentre pooled analysis of colon cancer trials (IMPACT) investigators. Lancet 1995;345:939-44.
38. O'Conell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichman C, Shepherd L, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1998;16:295-300.
39. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al. Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.
40. Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperativne radiotherapy for respectable rectal cancer: A meta-analysis. JAMA. 2000;284: 1008-15.
41. Cummings BJ, Rider WD, Harwood AR, Keane TJ, Thomas GM. Radical external beam radiation therapy for adenocarcinoma of the rectum. Dis Colon Rectum 1983; 26:30-6.
42. Marsh RDW. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronologically 5-fluorouracil infusion and radio therapy. Cancer 1996;78:217-25.
43. Onaitis MW, Noone RB, Fields R, Hurwitz H, Morse M, Jowell P et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 2001;8:801-6.
44. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264: 1444-50.